Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.66 USD | -1.06% | +4.49% | -7.19% |
05:57pm | Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $21 From $36, Maintains Overweight Rating | MT |
05-15 | Transcript : Abeona Therapeutics Inc., Q1 2024 Earnings Call, May 15, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.19% | 187M | |
+33.14% | 49.46B | |
+1.99% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+12.10% | 26.61B | |
-23.09% | 18.64B | |
+8.45% | 13.16B | |
+30.32% | 12.55B | |
+24.17% | 12.1B |
- Stock Market
- Equities
- ABEO Stock
- News Abeona Therapeutics Inc.
- Transcript : Abeona Therapeutics Inc., Q3 2023 Earnings Call, Nov 13, 2023